Aura Biosciences, Inc. (AURA) Reports In-Line Q2 EPS

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q2 EPS of ($0.47), in-line with the analyst estimate of ($0.47).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• On Holding AG (ONON) Stock: Market Doesn't Appreciate Brand's Potential, Says Analyst
• UBS starts CoreWeave at Buy in non-consensus call, sees 40% upside